CoChat

Insulin signalling promotes dendrite and synapse regeneration and restores circuit function after axonal injury

Open access
Agostinone, Jessica, Alarcon-Martinez, Luis, Gamlin, Clare, Yu, Wan-Qing, Wong, Rachel O L, Di Polo, Adriana · 2018 · Brain

The DOI matches its Crossref record; 104 of the 106 references it cites were found in a registry or an index.

Abstract

Dendrite pathology and synapse disassembly are critical features of chronic neurodegenerative diseases. In spite of this, the capacity of injured neurons to regenerate dendrites has been largely ignored. Here, we show that, upon axonal injury, retinal ganglion cells undergo rapid dendritic retraction and massive synapse loss that preceded neuronal death. Human recombinant insulin, administered as eye drops or systemically after dendritic arbour shrinkage and prior to cell loss, promoted robust regeneration of dendrites and successful reconnection with presynaptic targets. Insulin-mediated regeneration of excitatory postsynaptic sites on retinal ganglion cell dendritic processes increased neuronal survival and rescued light-triggered retinal responses. Further, we show that axotomy-induced dendrite retraction triggered substantial loss of the mammalian target of rapamycin (mTOR) activity exclusively in retinal ganglion cells, and that insulin fully reversed this response. Targeted loss-of-function experiments revealed that insulin-dependent activation of mTOR complex 1 (mTORC1) is required for new dendritic branching to restore arbour complexity, while complex 2 (mTORC2) drives dendritic process extension thus re-establishing field area. Our findings demonstrate that neurons in the mammalian central nervous system have the intrinsic capacity to regenerate dendrites and synapses after injury, and provide a strong rationale for the use of insulin and/or its analogues as pro-regenerative therapeutics for intractable neurodegenerative diseases including glaucoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awy142

Cites

104 of 104 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Insulin promotes dendritic regeneration in adult RGCs after axonal injury. (A–C) RGCs co-expressing YFP and SMI-32 (NF-H) with a clearly identifiable axon (arrowhead) were selected for dendritic arbour imaging and 3D reconstruction. (D and E) Three days after axotomy, RGCs had visibly smaller and simpler dendritic arbours relative to intact, non-injured neurons. (F) Human recombinant insulin or vehicle (PBS) were administered daily for four consecutive days by intraperitoneal injection (i.p.) or topically (eye drops) starting at 3 days post-axotomy, a time when there is already substantial dendrite retraction. RGC dendritic arbour analysis was carried out 7 days after injury. (G–J) Representative examples of dendritic arbours from axotomized retinas treated with vehicle or insulin, following the regimen described in (F), visualized at 7 days post-lesion (4 days of insulin treatment). (K–N) Quantitative analysis of dendritic parameters revealed that insulin-treated neurons had longer dendrites and markedly larger and more complex arbours than vehicle-treated controls (insulin i.p.: red, insulin eye drops: pink, PBS: dark grey). Values are expressed as the mean ± SEM. (ANOVA, ***P < 0.001, **P < 0.01, *P < 0.05, n = 4–6 mice/group, n = 28–46 RGCs/group, Table 1). The number of cells analysed in each group is indicated in Table 1. Scale bars: A–C = 25 µm, E–J = 50 µm.
Figure 1 Insulin promotes dendritic regeneration in adult RGCs after axonal injury. (A–C) RGCs co-expressing YFP and SMI-32 (NF-H) with a clearly identifiable axon (arrowhead) were selected for dendritic arbour imaging and 3D reconstruction. (D and E) Three days after axotomy, RGCs had visibly smaller and simpler dendritic arbours relative to intact, non-injured neurons. (F) Human recombinant insulin or vehicle (PBS) were administered daily for four consecutive days by intraperitoneal injection (i.p.) or topically (eye drops) starting at 3 days post-axotomy, a time when there is already substantial dendrite retraction. RGC dendritic arbour analysis was carried out 7 days after injury. (G–J) Representative examples of dendritic arbours from axotomized retinas treated with vehicle or insulin, following the regimen described in (F), visualized at 7 days post-lesion (4 days of insulin treatment). (K–N) Quantitative analysis of dendritic parameters revealed that insulin-treated neurons had longer dendrites and markedly larger and more complex arbours than vehicle-treated controls (insulin i.p.: red, insulin eye drops: pink, PBS: dark grey). Values are expressed as the mean ± SEM. (ANOVA, ***P < 0.001, **P < 0.01, *P < 0.05, n = 4–6 mice/group, n = 28–46 RGCs/group, Table 1). The number of cells analysed in each group is indicated in Table 1. Scale bars: A–C = 25 µm, E–J = 50 µm.CC BY-NC · PubMed Central
Figure 2 mTORC1 activity is required for insulin-mediated dendritic branching. (A–D) Immunohistochemical analysis of retinal cross sections with an antibody against pS6Ser240/244, a readout of mTORC1 function, and RBPMS, a selective marker of RGCs, revealed robust mTORC1 activity in these neurons. (E and F) Axonal injury induced a marked decrease of pS6Ser240/244 labelling in RGCs, suggesting loss of mTORC1 activity, which was restored by insulin treatment. (G) Co-administration of insulin with siRNA against Raptor (siRaptor), an essential component of mTORC1 function, blocked the effect of insulin on RGC-specific pS6Ser240/244 levels. (H) Quantification of the number of cells expressing both pS6Ser240/244 and RBPMS relative to all RBPMS-positive cells confirmed that insulin fully restored mTORC1 activity in injured RGCs relative to vehicle- or siRaptor-treated retinas (ANOVA, ***P < 0.001, n = 5 mice/group). (I–K) Western blot and densitometry analysis confirmed that intravitreal delivery of siRaptor reduced retinal Raptor protein while a non-targeting control siRNA (siCtl) had no effect (Student’s t-test, **P < 0.05, n.s. = not significant, n = 6–7 mice/group). siRaptor did not alter the levels of Rictor, confirming the specificity of the siRNA. The lower panel is the same blot as in the upper panel but probed with an antibody that recognizes β-actin to ensure equal protein loading. (L–N) Co-administration of insulin and siRaptor resulted in a marked loss of dendritic branches and simpler arbours relative to insulin alone or insulin combined with siCtl at 7 days post-injury. (O–R) Quantitative analysis of dendritic parameters, including Sholl analysis (P), confirmed that selective mTORC1 knockdown blocked the ability of insulin to increase the number of regenerating branches, while no significant changes in process length or arbour area were observed (Q and R) (ANOVA, ***P < 0.001, **P < 0.01, *P < 0.05, n.s. = not significant; n = 4–5 mice/group, n = 32–43 RGCs/group, Table 1). Values are expressed as the mean ± SEM. Scale bars: A–C and L–N = 50 µm, D–G = 25 µm. GCL = ganglion cell layer; INL = inner nuclear layer; IPL = inner plexiform layer; OPL = outer plexiform layer.
Figure 2 mTORC1 activity is required for insulin-mediated dendritic branching. (A–D) Immunohistochemical analysis of retinal cross sections with an antibody against pS6Ser240/244, a readout of mTORC1 function, and RBPMS, a selective marker of RGCs, revealed robust mTORC1 activity in these neurons. (E and F) Axonal injury induced a marked decrease of pS6Ser240/244 labelling in RGCs, suggesting loss of mTORC1 activity, which was restored by insulin treatment. (G) Co-administration of insulin with siRNA against Raptor (siRaptor), an essential component of mTORC1 function, blocked the effect of insulin on RGC-specific pS6Ser240/244 levels. (H) Quantification of the number of cells expressing both pS6Ser240/244 and RBPMS relative to all RBPMS-positive cells confirmed that insulin fully restored mTORC1 activity in injured RGCs relative to vehicle- or siRaptor-treated retinas (ANOVA, ***P < 0.001, n = 5 mice/group). (I–K) Western blot and densitometry analysis confirmed that intravitreal delivery of siRaptor reduced retinal Raptor protein while a non-targeting control siRNA (siCtl) had no effect (Student’s t-test, **P < 0.05, n.s. = not significant, n = 6–7 mice/group). siRaptor did not alter the levels of Rictor, confirming the specificity of the siRNA. The lower panel is the same blot as in the upper panel but probed with an antibody that recognizes β-actin to ensure equal protein loading. (L–N) Co-administration of insulin and siRaptor resulted in a marked loss of dendritic branches and simpler arbours relative to insulin alone or insulin combined with siCtl at 7 days post-injury. (O–R) Quantitative analysis of dendritic parameters, including Sholl analysis (P), confirmed that selective mTORC1 knockdown blocked the ability of insulin to increase the number of regenerating branches, while no significant changes in process length or arbour area were observed (Q and R) (ANOVA, ***P < 0.001, **P < 0.01, *P < 0.05, n.s. = not significant; n = 4–5 mice/group, n = 32–43 RGCs/group, Table 1). Values are expressed as the mean ± SEM. Scale bars: A–C and L–N = 50 µm, D–G = 25 µm. GCL = ganglion cell layer; INL = inner nuclear layer; IPL = inner plexiform layer; OPL = outer plexiform layer.CC BY-NC · PubMed Central
Figure 3 mTORC2 regulates process extension and length in regenerating dendritic arbours. (A and B) Western blot analysis of retinal homogenates demonstrated a substantial reduction of pAktSer473, a readout of mTORC2 activity, in axotomized retinas treated with vehicle, while insulin administration rescued pAktSer473 levels (ANOVA, **P < 0.01, *P < 0.05, n = 5 mice/group). The lower panel is the same blot probed with an antibody against total Akt for normalization. (C–F) Western blot and densitometry analyses demonstrated that intravitreal injection of siRNA against Rictor (siRictor) led to reduction of retinal Rictor protein while a non-targeting control siRNA (siCtl) had no effect. Rictor knockdown also resulted in pAktSer473 downregulation, indicative of mTORC2 function loss, but did not alter the levels of Raptor, thus validating its specificity (Student’s t-test, **P < 0.01, *P < 0.05, n.s. = not significant, n = 6–7 mice/group). The lowest panel represents the same blot probed with an antibody against β-actin to ensure equal protein loading. (G and H) Co-administration of insulin and siRictor resulted in a dramatic reduction in dendritic length and arbour area at 7 days post-injury relative to control retinas. (I) Administration of insulin and KU0063794 (KU), dual mTORC1 and mTORC2 inhibitor, resulted in overt dendrite degeneration characterized by a dramatic loss of branches and much shorter processes. Scale bars = 50 µm. (J–M) Quantitative analysis of dendritic parameters, including Sholl analysis (M), confirmed that siRictor-mediated mTORC2 inhibition resulted in a substantial loss of regenerating branches, while no significant changes in process length or arbour area were observed (ANOVA, ***P < 0.001, **P < 0.01, *P < 0.05, n.s. = not significant, n = 4–5 mice/group, n = 38–43 RGCs/group, Table 1). Values are expressed as the mean ± SEM.
Figure 3 mTORC2 regulates process extension and length in regenerating dendritic arbours. (A and B) Western blot analysis of retinal homogenates demonstrated a substantial reduction of pAktSer473, a readout of mTORC2 activity, in axotomized retinas treated with vehicle, while insulin administration rescued pAktSer473 levels (ANOVA, **P < 0.01, *P < 0.05, n = 5 mice/group). The lower panel is the same blot probed with an antibody against total Akt for normalization. (C–F) Western blot and densitometry analyses demonstrated that intravitreal injection of siRNA against Rictor (siRictor) led to reduction of retinal Rictor protein while a non-targeting control siRNA (siCtl) had no effect. Rictor knockdown also resulted in pAktSer473 downregulation, indicative of mTORC2 function loss, but did not alter the levels of Raptor, thus validating its specificity (Student’s t-test, **P < 0.01, *P < 0.05, n.s. = not significant, n = 6–7 mice/group). The lowest panel represents the same blot probed with an antibody against β-actin to ensure equal protein loading. (G and H) Co-administration of insulin and siRictor resulted in a dramatic reduction in dendritic length and arbour area at 7 days post-injury relative to control retinas. (I) Administration of insulin and KU0063794 (KU), dual mTORC1 and mTORC2 inhibitor, resulted in overt dendrite degeneration characterized by a dramatic loss of branches and much shorter processes. Scale bars = 50 µm. (J–M) Quantitative analysis of dendritic parameters, including Sholl analysis (M), confirmed that siRictor-mediated mTORC2 inhibition resulted in a substantial loss of regenerating branches, while no significant changes in process length or arbour area were observed (ANOVA, ***P < 0.001, **P < 0.01, *P < 0.05, n.s. = not significant, n = 4–5 mice/group, n = 38–43 RGCs/group, Table 1). Values are expressed as the mean ± SEM.CC BY-NC · PubMed Central
Figure 4 Insulin restores glutamatergic postsynaptic sites in injured neurons. (A) Glutamatergic synapses visualized in the inner plexiform layer (IPL) on retinal cross-sections using immunolabelling against VGLUT1 (green) and PSD95 (red), a pre- and a postsynaptic marker, respectively. (B and C) Axonal injury induced a pronounced loss of both VGLUT1 and PSD95 expression in the inner plexiform layer, which was completely restored by insulin treatment (analysis at 7 days post-axotomy). (D and E) High magnification of VGUT1 and PSD95 puncta in the inner plexiform layer at the level of the OFF sublamina in retinas treated with insulin or vehicle. (F) Quantitative analysis of pre- and postsynaptic co-localized voxels, which measured the 3D volume occupied by both VGLUT1 and PSD95 in the inner plexiform layer, confirmed that insulin promoted synaptic marker regeneration (insulin: red bar, vehicle: grey bar, ANOVA, ***P < 0.001, n = 4–6 mice/group). (G) Representative examples of biolistically labelled RGCs with plasmids encoding tdTomato (red, RGC dendrites) and PSD95-YFP (cyan, PSD95 puncta) at 7 days after axotomy. In the absence of treatment, many retraction bulbs and varicosities (yellow arrowheads) as well as abnormally large PSD95 puncta (white arrowheads) were observed. (H and I) Higher magnification of dendritic branch segments show abnormally large PSD95 clusters in vehicle-treated retinas relative to intact RGCs. (J–U) Analysis of 3D-reconstructed PSD95 puncta density along RGC dendrites demonstrated striking insulin-mediated regeneration of excitatory postsynaptic sites in ON-sustained, OFF-sustained, and OFF-transient alpha RGCs relative to vehicle-treated controls. (J’–T’) Higher magnification images of individual segments are provided to show PSD95-YFP puncta (blue) along dendrites (red) for each condition. Values are expressed as the mean ± SEM. (ANOVA, ***P < 0.001, **P < 0.01, n = 5–6 mice/group, n = 3–6 RGCs/group). Scale bars: A–C and G = 10 μm, D and E = 5 μm, H and I = 1 µm, J–S = 30 μm, J’–T’ = 2.5 μm. GCL = ganglion cell layer; INL = inner nuclear layer.
Figure 4 Insulin restores glutamatergic postsynaptic sites in injured neurons. (A) Glutamatergic synapses visualized in the inner plexiform layer (IPL) on retinal cross-sections using immunolabelling against VGLUT1 (green) and PSD95 (red), a pre- and a postsynaptic marker, respectively. (B and C) Axonal injury induced a pronounced loss of both VGLUT1 and PSD95 expression in the inner plexiform layer, which was completely restored by insulin treatment (analysis at 7 days post-axotomy). (D and E) High magnification of VGUT1 and PSD95 puncta in the inner plexiform layer at the level of the OFF sublamina in retinas treated with insulin or vehicle. (F) Quantitative analysis of pre- and postsynaptic co-localized voxels, which measured the 3D volume occupied by both VGLUT1 and PSD95 in the inner plexiform layer, confirmed that insulin promoted synaptic marker regeneration (insulin: red bar, vehicle: grey bar, ANOVA, ***P < 0.001, n = 4–6 mice/group). (G) Representative examples of biolistically labelled RGCs with plasmids encoding tdTomato (red, RGC dendrites) and PSD95-YFP (cyan, PSD95 puncta) at 7 days after axotomy. In the absence of treatment, many retraction bulbs and varicosities (yellow arrowheads) as well as abnormally large PSD95 puncta (white arrowheads) were observed. (H and I) Higher magnification of dendritic branch segments show abnormally large PSD95 clusters in vehicle-treated retinas relative to intact RGCs. (J–U) Analysis of 3D-reconstructed PSD95 puncta density along RGC dendrites demonstrated striking insulin-mediated regeneration of excitatory postsynaptic sites in ON-sustained, OFF-sustained, and OFF-transient alpha RGCs relative to vehicle-treated controls. (J’–T’) Higher magnification images of individual segments are provided to show PSD95-YFP puncta (blue) along dendrites (red) for each condition. Values are expressed as the mean ± SEM. (ANOVA, ***P < 0.001, **P < 0.01, n = 5–6 mice/group, n = 3–6 RGCs/group). Scale bars: A–C and G = 10 μm, D and E = 5 μm, H and I = 1 µm, J–S = 30 μm, J’–T’ = 2.5 μm. GCL = ganglion cell layer; INL = inner nuclear layer.CC BY-NC · PubMed Central
Figure 5 Insulin rescues retinal function and increases neuronal survival. (A–F) Representative examples of ERG recordings elicited by dim scotopic (A, C and E) or photopic (B, D and F) light stimulation prior to axotomy (pre-injury, black trace), or after axotomy and treatment with PBS (blue trace) or insulin (red trace). Pre- and post-axotomy recordings were normalized relative to the contralateral, non-injured eye (grey traces). (G and H) Quantitative analysis of the pSTR or PhNR amplitudes demonstrated restoration of RGC function in insulin-treated eyes relative to controls that received vehicle at 7 days post-axotomy (ANOVA, **P < 0.01, *P < 0.05, n = 4–6 mice/group). (I–K) Flat-mounted retinas from eyes treated with insulin displayed higher densities of RBPMS-positive RGCs compared to control retinas treated with vehicle at 1 week after optic nerve axotomy. (L) Co-administration of insulin with KU0063794 completely abrogated the pro-survival effect of insulin, strongly suggesting a role for both mTORC1 and mTORC2 in insulin-mediated RGC survival. Scale bars = 50 µm. (M) Quantitative analysis of RBPMS-positive cells confirmed that insulin (red) promoted significant RGC soma survival at 1, 2, 4, and 6 weeks after optic nerve lesion compared to control eyes treated with vehicle (grey), or a combination of insulin and KU0063794 (green). The densities of RGC soma in intact, non-injured animals is shown as reference (white, 100% survival). Systemic administration of KU0063794 alone did not induce RGC death in intact retinas ruling out any toxic effect of this compound. Values are expressed as the mean ± SEM. (ANOVA, ***P < 0.001, **P < 0.01, *P < 0.05, n = 5–6 mice/group).
Figure 5 Insulin rescues retinal function and increases neuronal survival. (A–F) Representative examples of ERG recordings elicited by dim scotopic (A, C and E) or photopic (B, D and F) light stimulation prior to axotomy (pre-injury, black trace), or after axotomy and treatment with PBS (blue trace) or insulin (red trace). Pre- and post-axotomy recordings were normalized relative to the contralateral, non-injured eye (grey traces). (G and H) Quantitative analysis of the pSTR or PhNR amplitudes demonstrated restoration of RGC function in insulin-treated eyes relative to controls that received vehicle at 7 days post-axotomy (ANOVA, **P < 0.01, *P < 0.05, n = 4–6 mice/group). (I–K) Flat-mounted retinas from eyes treated with insulin displayed higher densities of RBPMS-positive RGCs compared to control retinas treated with vehicle at 1 week after optic nerve axotomy. (L) Co-administration of insulin with KU0063794 completely abrogated the pro-survival effect of insulin, strongly suggesting a role for both mTORC1 and mTORC2 in insulin-mediated RGC survival. Scale bars = 50 µm. (M) Quantitative analysis of RBPMS-positive cells confirmed that insulin (red) promoted significant RGC soma survival at 1, 2, 4, and 6 weeks after optic nerve lesion compared to control eyes treated with vehicle (grey), or a combination of insulin and KU0063794 (green). The densities of RGC soma in intact, non-injured animals is shown as reference (white, 100% survival). Systemic administration of KU0063794 alone did not induce RGC death in intact retinas ruling out any toxic effect of this compound. Values are expressed as the mean ± SEM. (ANOVA, ***P < 0.001, **P < 0.01, *P < 0.05, n = 5–6 mice/group).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 104 references

Research works printed but not linked: 1

  1. Sarbassov, 2004, Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton, Curr Biol, 14, 1296, 10.1016/j.cub.2004.06.054 · DOI · Paper page

Cited by

See all 127

Metadata

Authors
Agostinone, J., Alarcon-Martinez, L., Gamlin, C., Yu, W.-Q., Wong, R. O. L., & Di Polo, A.
Affiliations
  • Centre Hospitalier de l’Université de Montréal (CA)
  • Department of Neuroscience, University of Montreal, Montreal, Quebec, Canada
  • University of Washington (US)
Venue
Brain
Published
2018-06-21
Volume
141
Issue
7
Pages
1963-1980
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2809644904
Cited by
124
References
106
Citations by year
2026: 8 · 2025: 9 · 2024: 20 · 2023: 18 · 2022: 16 · 2021: 28 · 2020: 18 · 2019: 4 · 2018: 3
FWCI
6.04
Type
journal article
Language
en
Open access
Locations
  • Brain (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • Glaucoma Research Foundation
  • Canadian Institutes of Health Research (MOP-125966)
  • National Institutes of Health (EY17101, EY01730)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords
insulin signaling, dendrite regeneration, synapse regeneration, axonal injury, retinal ganglion cells, dendritic retraction, synaptic loss, mTORC1, mTORC2, axotomy, dendritic branching, neuronal survival, glaucoma, neurodegeneration
MeSH terms
Mechanistic Target of Rapamycin Complex 1, Mechanistic Target of Rapamycin Complex 2, Animals, Axons, Central Nervous System, Dendrites, Glaucoma, Insulin, Nerve Regeneration, Optic Nerve, Retina, Retinal Ganglion Cells, Synapses, Signal Transduction, Optic Nerve Injuries, Mice, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insulin signalling promotes dendrite and synapse regeneration and restores circuit function after axonal injury. https://app.cochat.ai/papers/10.1093/brain/awy142
The paper
Agostinone, J., Alarcon-Martinez, L., Gamlin, C., Yu, W.-Q., Wong, R. O. L., & Di Polo, A. (2018). Insulin signalling promotes dendrite and synapse regeneration and restores circuit function after axonal injury. Brain. https://doi.org/10.1093/brain/awy142

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.